These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7821679)

  • 1. A novel acetylcholinesterase inhibitor, Ro 46-5934, which interacts with muscarinic M2 receptors.
    Borroni E; Damsma G; Giovacchini C; Mutel V; Jakob-Rötne R; Da Prada M
    Biochem Soc Trans; 1994 Aug; 22(3):755-8. PubMed ID: 7821679
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum.
    Liu J; Chakraborti T; Pope C
    Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition.
    Messamore E; Warpman U; Williams E; Giacobini E
    Neurosci Lett; 1993 Aug; 158(2):205-8. PubMed ID: 8233096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptors.
    Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):144-8. PubMed ID: 11176279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum.
    Messamore E; Ogane N; Giacobini E
    Neuropharmacology; 1993 Mar; 32(3):291-6. PubMed ID: 8474626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rivastigmine on scopolamine-induced memory impairment in rats.
    Bejar C; Wang RH; Weinstock M
    Eur J Pharmacol; 1999 Nov; 383(3):231-40. PubMed ID: 10594314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
    Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
    Bymaster FP; Wong DT; Mitch CH; Ward JS; Calligaro DO; Schoepp DD; Shannon HE; Sheardown MJ; Olesen PH; Suzdak PD; Swedberg MD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):282-9. PubMed ID: 7909558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
    Korczyn AD
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic acetylcholinesterase inhibition regulates in vivo the localization and abundance of muscarinic receptors m2 and m4 at the cell surface and in the cytoplasm of striatal neurons.
    Liste I; Bernard V; Bloch B
    Mol Cell Neurosci; 2002 Jun; 20(2):244-56. PubMed ID: 12093157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.
    Smail MA; Soles JL; Karwoski TE; Rubin RT; Rhodes ME
    Brain Res Bull; 2018 Mar; 137():23-34. PubMed ID: 29122691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats.
    Xiao WB; Nordberg A; Zhang X
    J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholinesterase inhibitor].
    Ueki A; Miyoshi K
    Nihon Rinsho; 1991 Sep; 49(9):2024-31. PubMed ID: 1960871
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe.
    Sánchez-Roa PM; Wagner HN; Villemagne VL; London ED; Lever JR
    Eur J Pharmacol; 1998 Oct; 358(3):207-11. PubMed ID: 9822886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic effect of tacrine on acetylcholine release in rat brain via M1 and M2 receptors.
    Svensson AL; Zhang X; Nordberg A
    Brain Res; 1996 Jul; 726(1-2):207-12. PubMed ID: 8836562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
    Huff RA; Corcoran JJ; Anderson JK; Abou-Donia MB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats.
    Karanth S; Liu J; Ray A; Pope C
    Toxicology; 2007 Oct; 239(3):167-79. PubMed ID: 17707571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic excitation in grasshopper song control circuits is limited by acetylcholinesterase activity.
    Hoffmann K; Wirmer A; Kunst M; Gocht D; Heinrich R
    Zoolog Sci; 2007 Oct; 24(10):1028-35. PubMed ID: 18088166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of muscarinic receptor density and acetylcholinesterase activity in repeated DFP-treated rats after the termination of DFP administration.
    Lim DK; Hoskins B; Ho IK
    Eur J Pharmacol; 1986 Apr; 123(2):223-8. PubMed ID: 3709665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.